cancer immunotherapy – Page 4 – PROSTATE WARRIORS – The latest news about prostate cancer

Tag Archive for: cancer immunotherapy

MDNA113 a Potentially Groundbreaking Immune Therapy for Solid Tumors Including mCRPC

June 30, 2025/in Immunotherapy, Preclinical Research/by Max

Phase 2 Trial: ZG006 a New Immunotherapy for Neuroendocrine Prostate Cancer

June 19, 2025/in Clinical Trial, Metastatic, Phase 2/by Max

Phase 1 Trial for DR-0202 Bispecific Antibody for Solid Tumors

June 17, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

Positive Results From Phase 3 Trial of CAN-2409 for Localized Prostate Cancer Led to RMAT Designation

May 29, 2025/in Clinical Trial, Non-Metastatic, Phase 3/by Max

Phase 1 Study Results of JNJ-78278343 (pasritamig) in mCRPC

May 23, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

Retrospective Study On Real World Data: Sipuleucel-T Shows Encouraging Results in mCRPC

May 23, 2025/in Retrospective studies/by Max

Q702 Drug Shows Promise in Early Trials: Could Be Useful Against Prostate Cancer

April 25, 2025/in Clinical Trial, Not PCa related/by Max

Next-Generation ADCs for Cancer Treatment with Potential in Prostate Cancer

April 24, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

CD-001: A Promising Novel Dual-Targeting Immunotherapy

April 19, 2025/in Immunotherapy, Preclinical Research/by Max

Phase 1 Enrolling: Sylvester Cancer Center Launches Innovative Clinical Trial for High-Grade Neuroendocrine Tumors

April 10, 2025/in Clinical Trial, Metastatic, Phase 1/by Max